alzheimer-s-disease

Documents about alzheimer-s-disease

• New perspectives on VEGF signalling in Alzheimer's disease.#422805NCBI PubMed Central
• AD-GPT: large language models in Alzheimer's disease.#433925NCBI PubMed Central
• APOE-ε4 genotype and western diet synergistically aggravate synaptic dysfunction in Alzheimer’s disease via d-serine disruption#7844HAL (France)
• Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer’s disease#205386Figshare
• Circulating sphingomyelins correlate with plasma T-tau in cognitively unimpaired older adults at risk of developing Alzheimer's disease#320845Research Online
• Interpretable deep survival analysis of Alzheimer's disease via metabolic genetic variants.#251014NCBI PubMed Central
• Expression of GPR34 in microglia remains stable in human Alzheimer's disease.#284899NCBI PubMed Central
• Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup.#125278NCBI PubMed Central
• Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty#614653eScholarship
• Retention of Study Partners in Longitudinal Studies of Alzheimer Disease#634739eScholarship
• Cardiovascular Disease Subtypes and Alzheimer's Disease: Phenotypic and Genetic Associations in the UK Biobank and All of Us Research Program#383743Digital Commons @ Michigan Tech
• Enhancing brain delivery of tegaserod for Alzheimer’s disease: a pharmaceutical comparison of two nanocarrier-based strategies#388152HAL (France)
• Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project#5492Europe PMC
• Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS).#284876NCBI PubMed Central
• Identification de facteurs de risque génétique liés au sexe pour la maladie d'Alzheimer#14158HAL (France)
• Situación actual de los indicadores de mortalidad por Alzheimer en Castilla y León#438757Gestión del Repositorio Documental de la Universidad de Salamanca
• Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimers disease in metabolically stressed APPswe/PS1dE9 mice#230965Dipòsit Digital de la Universitat de Barcelona
• System changes to empower primary care in Alzheimer's disease detection and care.#143063NCBI PubMed Central
• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing#143862bioRxiv / medRxiv
• Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true?#154483NCBI PubMed Central
• Investigating causal associations among inflammatory proteins, blood metabolites, and Alzheimer's disease risk.#322992NCBI PubMed Central
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths.#123059NCBI PubMed Central
• A brain-penetrant P2X7R antagonist mitigates Alzheimer's disease pathology#162286bioRxiv / medRxiv
• Minor neuropsychological deficits and stage 2 of Alzheimer's disease.#185795NCBI PubMed Central
• Path integration in Alzheimer’s disease: orientation, movement and theta rhythmicity#196163PMC Full-Text (OAI)
• Continuum of Core 1 biomarkers in preclinical Alzheimer's disease.#242159NCBI PubMed Central
• Advances in the treatment of Alzheimer's disease.#334841NCBI PubMed Central
• Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease#360073HAL (France)
• Data-Driven Stochastic Model for Detecting Patientswith Alzheimer's Disease#363407bioRxiv / medRxiv
• Hunting for an Antigen: Humoral Immunity in Alzheimer's Disease.#367984NCBI PubMed Central
• Human Microglial Molecular Alterations in Aging and Alzheimer's Disease.#367989NCBI PubMed Central
• APOE4 Drives Uniquely Dysfunctional Human Microglial States in Alzheimer's Disease#379836bioRxiv / medRxiv
• Mapping Alzheimer's disease heterogeneity through exploratory unsupervised learning.#418313NCBI PubMed Central
• 42 U.S.C. § 247a — Family support groups for Alzheimer’s disease patients#595353US Code (LII)
• Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study#126052ClinicalTrials.gov
• Psychopathologie de la maladie d'Alzheimer : une approche clinique de la mémoire démentielle#235293HAL (France)
• MALDI mass spectrometry imaging (MSI) reveals molecular and structural heterogeneity of amyloid-β in sporadic Alzheimer's disease and Down syndrome#5545Europe PMC
• Defying syntactic preservation in Alzheimer's disease: What type of impairment predicts syntactic change in dementia (if it does) and why?#377723Gestión del Repositorio Documental de la Universidad de Salamanca
• Sex-specific genetic predictors of Alzheimer’s disease biomarkers#642066eScholarship
• Neurophysiological trajectories in Alzheimer’s disease progression#642170eScholarship
• Effects of mindfulness-based exercise on Parkinson's disease and Alzheimer's disease: a systematic review and meta-analysis.#455065NCBI PubMed Central
• The contribution of a high-fat diet to neurodegeneration and oxidative stress in a drosophila melanogaster model of Alzheimer’s disease#483925University of Nottingham Repository
• HIF-1α downregulates the APP protein after oxygen and glucose deprivation in the APPswe/PSEN1 mouse model of Alzheimer’s disease#205302e-cienciaDatos Dataverse OAI Archive
• Gut microbiome composition, metabolic activity, and dietary associations in preclinical Alzheimer’s disease#336317Research Online
• Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics#161197HAL (France)
• Studying the interaction between Polyoxometalates and Amyloid peptides in the context of Alzheimer’s disease#195713HAL (France)
• Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans#614673eScholarship
• Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.#148152NCBI PubMed Central
• Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease#148864bioRxiv / medRxiv
• Grey- and white-matter resilience to tau, cognition and sex in Alzheimer's disease#379854bioRxiv / medRxiv